Liver Fibrosis Market Industry Analysis and Forecast by 2029
Data Bridge Market Research analyses that the liver fibrosis market was valued at USD 16.45 billion in 2021 and is expected to reach USD 38.74 billion by 2029, registering a CAGR of 11.30% during the forecast period of 2022 to 2029. Market Definition Repeated or persistent liver damage results in an unusually high quantity of scar tissue in the liver, which is known as liver fibrosis. Fibrosis has no symptoms, but extensive scarring causes cirrhosis, which causes symptoms. Healthcare providers use blood and imaging tests to determine the severity of the condition, and liver biopsy. Healthcare practitioners focus on treating the source of liver fibrosis, which often stops or slows additional scarring of the liver and leads to a better outcome. Antiviral medications and the removal or dissolution of a blockage in the bile ducts, are all potential treatments for liver fibrosis. Global Liver Fibrosis Market Scope The liver fibrosis market is segmented on the basis of condition, diagnosis, ...